| Joyce A Noriega, MD | |
|
2097 Henry Tecklenburg Dr Ste 311w, Charleston, SC 29414-5744 | |
| (843) 789-1800 | |
| (843) 606-8036 |
| Full Name | Joyce A Noriega |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 2097 Henry Tecklenburg Dr Ste 311w, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881677326 | NPI | - | NPPES |
| 276944 | Medicaid | SC | |
| GP4260 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 27694 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bon Secours-st Francis Xavier Hospital | Charleston, SC | Hospital |
| Roper Hospital | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Roper Saint Francis Physicians Network | 5193874824 | 415 |
News Archive
Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
Equipois Inc., designer and manufacturer of the zeroG® mechanical arm technology, debuted today the x-Ar™, the world's first exoskeletal arm support system for manual tasks, at the Applied Ergonomics Conference in Orlando, Florida.
› Verified 6 days ago
| Entity Name | Fetter Health Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003827304 PECOS PAC ID: 9032215199 Enrollment ID: O20070507000192 |
News Archive
Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
Equipois Inc., designer and manufacturer of the zeroG® mechanical arm technology, debuted today the x-Ar™, the world's first exoskeletal arm support system for manual tasks, at the Applied Ergonomics Conference in Orlando, Florida.
› Verified 6 days ago
| Entity Name | Roper Saint Francis Physicians Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346752383 PECOS PAC ID: 5193874824 Enrollment ID: O20090528000405 |
News Archive
Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
Equipois Inc., designer and manufacturer of the zeroG® mechanical arm technology, debuted today the x-Ar™, the world's first exoskeletal arm support system for manual tasks, at the Applied Ergonomics Conference in Orlando, Florida.
› Verified 6 days ago
| Entity Name | Obhg South Carolina Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538457361 PECOS PAC ID: 7012182504 Enrollment ID: O20111212000681 |
News Archive
Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
Equipois Inc., designer and manufacturer of the zeroG® mechanical arm technology, debuted today the x-Ar™, the world's first exoskeletal arm support system for manual tasks, at the Applied Ergonomics Conference in Orlando, Florida.
› Verified 6 days ago
| Entity Name | Fetter Health Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982124301 PECOS PAC ID: 9032215199 Enrollment ID: O20171228002000 |
News Archive
Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
Equipois Inc., designer and manufacturer of the zeroG® mechanical arm technology, debuted today the x-Ar™, the world's first exoskeletal arm support system for manual tasks, at the Applied Ergonomics Conference in Orlando, Florida.
› Verified 6 days ago
| Entity Name | Fetter Health Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518454818 PECOS PAC ID: 9032215199 Enrollment ID: O20190118001672 |
News Archive
Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
Equipois Inc., designer and manufacturer of the zeroG® mechanical arm technology, debuted today the x-Ar™, the world's first exoskeletal arm support system for manual tasks, at the Applied Ergonomics Conference in Orlando, Florida.
› Verified 6 days ago
| Entity Name | Fetter Health Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659872059 PECOS PAC ID: 9032215199 Enrollment ID: O20190930000858 |
News Archive
Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
Equipois Inc., designer and manufacturer of the zeroG® mechanical arm technology, debuted today the x-Ar™, the world's first exoskeletal arm support system for manual tasks, at the Applied Ergonomics Conference in Orlando, Florida.
› Verified 6 days ago
| Entity Name | Uwh Of The Carolinas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639506470 PECOS PAC ID: 0042448169 Enrollment ID: O20210318002461 |
News Archive
Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
Equipois Inc., designer and manufacturer of the zeroG® mechanical arm technology, debuted today the x-Ar™, the world's first exoskeletal arm support system for manual tasks, at the Applied Ergonomics Conference in Orlando, Florida.
› Verified 6 days ago
| Entity Name | Fetter Health Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457007841 PECOS PAC ID: 9032215199 Enrollment ID: O20221012001595 |
News Archive
Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
Equipois Inc., designer and manufacturer of the zeroG® mechanical arm technology, debuted today the x-Ar™, the world's first exoskeletal arm support system for manual tasks, at the Applied Ergonomics Conference in Orlando, Florida.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joyce A Noriega, MD Po Box 751649, Charlotte, NC 28275-1649 Ph: (843) 789-1620 | Joyce A Noriega, MD 2097 Henry Tecklenburg Dr Ste 311w, Charleston, SC 29414-5744 Ph: (843) 789-1800 |
News Archive
Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
Equipois Inc., designer and manufacturer of the zeroG® mechanical arm technology, debuted today the x-Ar™, the world's first exoskeletal arm support system for manual tasks, at the Applied Ergonomics Conference in Orlando, Florida.
› Verified 6 days ago
Bethany Anne Bruno, MD, MA Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-2300 | |
Matthew Kohler, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Ashlyn Holstein Savage, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Elsa C Caire, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2097 Henry Tecklenburg Dr, Suite 312w, Charleston, SC 29414 Phone: 843-769-5620 Fax: 843-769-5625 | |
Paula E Orr, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5319 Parkshire Way, Charleston, SC 29418 Phone: 843-767-2121 Fax: 843-767-2102 | |
Monica June Mitchum, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1027 Physicians Dr Ste 110, Charleston, SC 29414 Phone: 843-740-6700 Fax: 843-745-9428 | |
Phillip Andres Rodriguez, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 843-792-7108 |